Cargando…

EHMTI-0036. Gammacore device for treatment of migraine attack: preliminary report

Detalles Bibliográficos
Autores principales:	Grazzi, L, Usai, S, Bussone, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182236/ http://dx.doi.org/10.1186/1129-2377-15-S1-G12

Ejemplares similares

EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014)

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
por: Vetvik, KG, et al.
Publicado: (2014)

EHMTI-0044. Variability of clinical features in attacks of migraine with aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0362. Non-invasive vagus nerve stimulation with gammacore® for prevention and acute treatment of chronic cluster headache: report from the extension phase of the preva study
por: Gaul, C, et al.
Publicado: (2014)

EHMTI-0363. Quality of life in subjects treated by non-invasive vagus nerve stimulation using gammacore® for the prevention and acute treatment of chronic cluster headache
por: Gaul, C, et al.
Publicado: (2014)

EHMTI-0052. Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, G, et al.
Publicado: (2014)

EHMTI-0364. Non-invasive vagus nerve stimulation using gammacore® for prevention and acute treatment of chronic cluster headache: report from the randomized phase of the preva study
por: Gaul, C, et al.
Publicado: (2014)

EHMTI-0193. The impact of cognitive symptoms on migraine attack related disability
por: Gil-Gouveia, R, et al.
Publicado: (2014)

EHMTI-0174. Dural vessel hemodynamics during normal behavior and migraine attack
por: Gao, Y, et al.
Publicado: (2014)

PS 0036-0344
Publicado: (2007)

EHMTI-0318. The place of corticosteroids in migraine attack management: systematic review and critical appraisal
por: Woldeamanuel, YW, et al.
Publicado: (2014)

EHMTI-0181. Fast recovery of visual evoked potential amplitude after photostress in migraine patients between attacks
por: Coppola, G, et al.
Publicado: (2014)

EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase
por: Song, G, et al.
Publicado: (2014)

EHMTI-0107. Treatment of migraine in Croatia, year 2013
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

EHMTI-0104. VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

EHMTI-0086. Pure mestrual vestibular migraine
por: Mostardini, C, et al.
Publicado: (2014)

EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications
por: Tfelt-Hansen, P, et al.
Publicado: (2014)

EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine
por: Schankin, C, et al.
Publicado: (2014)

EHMTI-0206. Nigerian plants that are used for treatment of headache and migraine
por: Saganuwan, SA
Publicado: (2014)

EHMTI-0049. Headache, migraine and epileptic seizures
por: Gligic, N, et al.
Publicado: (2014)

EHMTI-0089. Relationship of sleep bruxism and migraine
por: Kato, M, et al.
Publicado: (2014)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

EHMTI-0358. Improved chronic migraine after DTMS
por: Scatena, P, et al.
Publicado: (2014)

EHMTI-0140. The potential role of levetiracetam in migraine treatment: an animal study
por: Wang, YF, et al.
Publicado: (2014)

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014)

EHMTI-0122. Serum micrornas as potential biomarkers of migraine
por: Andersen, HH, et al.
Publicado: (2014)

EHMTI-0348. Refractive errors in patients with migraine headache
por: Gunes, A, et al.
Publicado: (2014)

EHMTI-0050. Systemic and cerebral endothelial function in migraine
por: Zaletel, M, et al.
Publicado: (2014)

EHMTI-0070. Effect of occlusal sprint in migraine patients
por: Takeuchi, M, et al.
Publicado: (2014)

EHMTI-0374. Gene-based pleiotropy across migraine with and migraine without aura
por: Nyholt, D, et al.
Publicado: (2014)

EHMTI-0026. Neuroprolotherapy and acupuncture for clinical trial of acute and chronic migraine treatment
por: Schulman, R
Publicado: (2014)

EHMTI-0187. A novel ATP1A2 mutation in a case of familial hemiplegic migraine with especially severe attacks
por: Martínez, E, et al.
Publicado: (2014)

EHMTI-0087. Use of oxicodone/naloxone extended release for menstrual migraine
por: Mostardini, C, et al.
Publicado: (2014)

EHMTI-0249. Headache attributed to hypertension in chronic migraine patients
por: Grosu, O, et al.
Publicado: (2014)

EHMTI-0080. How migraine is affected by therapies for multiple sclerosis
por: Condello, C, et al.
Publicado: (2014)

EHMTI-0030. Migraine pain location in adult: the bangladeshi experience
por: Haque, R
Publicado: (2014)

EHMTI-0194. The impact of dizziness in tertiary care migraine patients
por: Sugrue, J, et al.
Publicado: (2014)

EHMTI-0055. Abnormal thalamic function in patients with vestibular migraine
por: Russo, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jtm0rirc6rhekmdq31bkrpisv5